Sword Health, a digital therapeutics company that started in the physical therapy space, has acquired digital mental health ...

Medical technology company Boston Scientific became the target of a cyberattack this week, which disrupted some of its IT ...

The US FDA has green lit ViiV Healthcare’s Tivicay PD (dolutegravir) for the treatment of HIV-1 in children weighing at least ...

The Marcus Evans AI, Forecasting, Insights and Analytics for Smarter Decisions in Pharma conference will explore how pharma ...

The ambition to build a Phase I oncology clinical development centre can be deceptively simple. The temptation is to ...

Pharmaceutical portfolio decision-making is facing structural pressure. Patent expirations, rising development costs, ...

AstraZeneca and Amgen have announced the first Phase III results for Tezspire (tezepelumab) in eosinophilic oesophagitis (EoE ...

Pharma R&D leaders in Europe are facing a rare convergence of pressures: a historic patent cliff, tightening EU/UK pricing ...

While obesity may be a fast-growing cost area, it's far from the largest -- only 10% of employers surveyed put it in their ...

Jazz Pharmaceuticals has been granted US approval for two combinations of its cancer drug Ziihera for people with advanced ...

Europe. Whilst long recognised as Europe's largest partnering conference, it's now expanding to become the continent's most ...

Spyre Therapeutics’ hopes for its anti-TL1A antibody SPY072 in rheumatoid arthritis (RA) have hit a bump in the road after ...